{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:07:39Z","timestamp":1784700459422,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peptidylarginine Deiminase\/Protein Arginine Deiminase (PAD\/PADI) are a family of enzymes that catalyze protein citrullination, converting arginine residues to citrulline residues in a calcium-dependent manner. The net loss of positive charge of protein citrullination results in change of conformation, including probable formation of neoepitopes, and interactions with substances like DNA, which contributes to physiologic and pathophysiologic processes such as regulation of gene expression, Neutrophil Extracellular Traps (NETs), Rheumatoid Arthritis (RA), and Multiple Sclerosis (MS). To date, studies of PADs pan- and selective inhibitors have been deepening. This bibliometric analysis tries to give a comprehensive conclusion on research progress of peptidylarginine deiminases (PAD) and PAD inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we aggregated publications using a dual-database strategy (Web of Science and PubMed) from January 1, 2006, to December 5, 2025, with a specific focus on the arginine deiminase research. Utilizing bibliometric methods, the data underwent processing to facilitate visual analysis of various aspects, including countries, institutions, authors, co-citations, keywords, references, gene characteristics, and diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the past two decades, the number of publications on the PAD family has increased continuously, with the United States contributing the largest number of publications. The University of Massachusetts emerged as the most prolific institution with 73 publications, while Paul R. Thompson was identified as the leading author in this field. Frontiers in Immunology published the highest number of PAD-related articles. High-frequency keywords included \u201crheumatoid arthritis\u201d, \u201cneutrophil extracellular traps\u201d, \u201ccitrullination\u201d, \u201cPADI\u201d, and \u201carginine deiminase\u201d. Recent trends, identified through strong citation bursts from 2022 to 2025, include neutrophil extracellular traps, PADI4, and the tumor microenvironment. The high-frequency genes in the PADs field include PADI4, PADI2, TP53, and MPO. Additionally, pathways such as Lipid and atherosclerosis and viral infection-related pathways are significantly enriched in this research domain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The research maps the evolving landscape of PAD research over the past two decades. However, cooperation between institutions and countries remains limited, although trends indicate increasing cooperation. This study identifies major research hotspots and evolving trends within the PAD field, helping to guide future research directions and providing an objective, data-driven reference for tracking new frontiers in the field, rather than drawing biological conclusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1784910","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:40Z","timestamp":1784699800000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bibliometric and visualization analysis of arginine deiminase research from 2006 to 2025: trends, collaboration networks and emerging frontiers"],"prefix":"10.3389","volume":"17","author":[{"given":"Songtao","family":"Jiang","sequence":"first","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lebin","family":"Gan","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozheng","family":"Cao","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Jin","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Chang","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbing","family":"Wang","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ye","sequence":"additional","affiliation":[{"name":"Trauma Treatment Center, Peking University People\u2019s Hospital; Key Laboratory of Trauma Treatment and Neural Regeneration (Peking University) Ministry of Education; National Center for Trauma Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.01.014","article-title":"Insights into peptidylarginine deiminase expression and citrullination pathways","volume":"32","author":"Yu","year":"2022","journal-title":"Trends Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109134","article-title":"Citrullination: a modification important in the pathogenesis of autoimmune diseases","volume":"245","author":"Zhu","year":"2022","journal-title":"Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-020-01221-0","article-title":"Inhibition of PAD2 improves survival in a mouse model of lethal LPS-induced endotoxic shock","volume":"43","author":"Wu","year":"2020","journal-title":"Inflammation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.869706","article-title":"Extracellular DNA traps: origin, function and implications for anti-cancer therapies","volume":"12","author":"Mamtimin","year":"2022","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/s41467-023-36620-y","article-title":"Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis","volume":"14","author":"Curran","year":"2023","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678953","article-title":"Citrullination and PAD enzyme biology in type 1 diabetes - regulators of inflammation, autoimmunity, and pathology","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a133189","article-title":"Properties of peptidylarginine deiminase from the epidermis of newborn rats","volume":"89","author":"Fujisaki","year":"1981","journal-title":"J Biochem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"Bioessays"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb799","article-title":"Structural basis for Ca(2+)-induced activation of human PAD4","volume":"11","author":"Arita","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000452","article-title":"Rheumatoid arthritis and citrullination","volume":"30","author":"Darrah","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0143-1","article-title":"The roles of DNA, RNA and histone methylation in ageing and cancer","volume":"20","author":"Michalak","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.971121","article-title":"Increased histone citrullination in juvenile idiopathic arthritis","volume":"9","author":"Parackova","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2873","article-title":"Unconventional post-translational modifications in immunological signaling","volume":"15","author":"Mowen","year":"2014","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1195747","article-title":"Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment","volume":"10","author":"van den Beukel","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/182186a0","article-title":"Content of citrulline and other amino-acids in a protein of hair follicles","volume":"182","author":"Rogers","year":"1958","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00018-024-05319-8","article-title":"Unconventional posttranslational modification in innate immunity","volume":"81","author":"Chen","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-021-01373-z","article-title":"Histone citrullination: a new target for tumors","volume":"20","author":"Zhu","year":"2021","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201906334","article-title":"Halogen bonding increases the potency and isozyme selectivity of protein arginine deiminase 1 inhibitors","volume":"58","author":"Mondal","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2019.01.024","article-title":"Peptidyl arginine deiminases: detection and functional analysis of protein citrullination","volume":"59","author":"Tilvawala","year":"2019","journal-title":"Curr Opin Struct Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00225","article-title":"Calcium regulates the nuclear localization of protein arginine deiminase 2","volume":"58","author":"Zheng","year":"2019","journal-title":"Biochemistry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102162","article-title":"New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors","volume":"15","author":"Jia","year":"2025","journal-title":"Results Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117830","article-title":"Discovery of highly potent naphthalene\/quinoline-based PAD inhibitors: structure-activity relationship, selectivity, and cytotoxicity","volume":"296","author":"Jia","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112414","article-title":"PAD4 and its inhibitors in cancer progression and prognosis","volume":"14","author":"Zhu","year":"2022","journal-title":"Pharmaceutics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.802934","article-title":"Anti-citrullinated protein antibody generation, pathogenesis, clinical application, and prospects","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152699","article-title":"The autoantibody response in rheumatoid arthritis; what makes it unique","author":"Toes","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103734","article-title":"Insights into the complexities of citrullination: from immune regulation to autoimmune disease","volume":"24","author":"Wang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134662","article-title":"Putative roles for peptidylarginine deiminases in COVID-19","volume":"21","author":"Arisan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1167362","article-title":"Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies","volume":"15","author":"Bashar","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.97166","article-title":"AFM41a: a novel PAD2 inhibitor for sepsis treatment-efficacy and mechanism","volume":"20","author":"Dong","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12931-024-02923-x","article-title":"The role of extracellular traps released by neutrophils, eosinophils, and macrophages in asthma","volume":"25","author":"Gu","year":"2024","journal-title":"Respir Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1717671","article-title":"Neutrophil extracellular traps in rheumatoid arthritis: pathogenic mechanisms and therapeutic potential","volume":"16","author":"Mao","year":"2025","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10571-024-01470-9","article-title":"Neutrophil extracellular traps regulate surgical brain injury by activating the cGAS-STING pathway","volume":"44","author":"Li","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.neuron.2023.06.024","article-title":"PLA2G2E-mediated lipid metabolism triggers brain-autonomous neural repair after ischemic stroke","volume":"111","author":"Nakamura","year":"2023","journal-title":"Neuron"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.1038\/s41467-024-53554-1","article-title":"A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation","volume":"15","author":"Bertran","year":"2024","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s13402-024-01013-w","article-title":"Lenvatinib-activated NDUFA4L2\/IL33\/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma","volume":"48","author":"Yi","year":"2025","journal-title":"Cell Oncol (Dordr)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113289","article-title":"Anti-PADI4 antibody suppresses breast cancer by repressing the citrullinated fibronectin in the tumor microenvironment","volume":"153","author":"Wang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.06.029","article-title":"Icaritin inhibits the progression of urothelial cancer by suppressing PADI2-mediated neutrophil infiltration and neutrophil extracellular trap formation","volume":"14","author":"Mou","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00024","article-title":"Protein arginine deiminases (PADs): biochemistry and chemical biology of protein citrullination","volume":"52","author":"Mondal","year":"2019","journal-title":"Acc Chem Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12932","article-title":"Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis","volume":"188","author":"Willis","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00274","article-title":"Development of a selective inhibitor of protein arginine deiminase 2","volume":"60","author":"Muth","year":"2017","journal-title":"J Med Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1784910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:41Z","timestamp":1784699801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1784910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2026.1784910"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1784910","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1784910"}}